Time Hall A Hall B Hall C
09:00 – 10:30 S4. Diagnostic approach to hemostasis disorders


Brent L. Wood & Pat Twomey

S22. Laboratory testing guideline in the intensive care unit


Sezer Uysal & Yeşim Özarda

Coagulation testing and new oral anticoagulants
Sophie Testa
The role of laboratory medicine in intensive care unit
Beliz Bilgili
Thrombin generation analysis: research tool, biomarker or intermediate phenotype?

Tilman Hackeng

Inflammation versus sepsis: Focus on biomarkers
Michael Meisner
Diagnostic approach to hemostasis disorders
Hugo ten Cate
TDM of antibiotics
Paul M. Tulkens
10:30 – 10:45 Coffee Break & Posters
10:45 – 11:30 Plenary Lecture: Liquid biopsy for cancer screening

Chair:Siraj Misbah

Speaker:Michael Neumaier

11:30 – 12:10 Industry-Sponsored Symposium




Analytical Comparison Between Mindray CAL-8000 vs Sysmex XN-9000 Hematology Analyzers
Michela Seghezzi


12:10 – 13:00 Lunch & Posters
13:00 – 14:30 WASPALM Symposium


Ozkan Alatas & Roberto Verna

S5. Detecting kidney disease: From proteomics to the clinical laboratory


Eberhard Wieland & Tomas Zima

Oral Presentations


Metin Kılınç & Hülya Aybek

13:00-13:10 How Are The Identification Errors Occur In Medical Laboratory Processes? Four Sample Cases From Real Laboratory Life.
Pinar Eker
13:10-13:20 Human Leucocyte Antigen B27 Measurement Using Flow Cytometry After 5 Days of Sample Collection.
Murat Koser
13:20-13:30 Impact Of Storage Conditions On The Natriuretic Peptides Pre-Analytical Stability Using Different Analytical Methods And Biological Variability Concept.
Coumba Diop
13:30-13:40 Analysis Of Daily Variation In Serum Prolactin Levels Of Women In Reproductive Age With Data Mining
Deniz İlhan Topcu
13:40-13:50 Effective Utilization Rates, Awareness Of Quality Indicators And Expectations From Medical Laboratories, A Pilot Study From Turkey
M. Erinc Sitar
13:50-14:00 Analysis Of Coagulation Unit Preanalytical Quality By Six Sigma And Pareto: In Sample Collection
Fatma Ceyla Eraldemir
14:00-14:10 Rational Use of Laboratory Test Request Procedure: University Experience for Vitamin B12 and Folate Tests
Habib Ozdemir
14:10-14:20 Effect of Pneumatic Tube Delivery System on Hemolysis-Is it Clinically Significant?
Dilara Karacan
14:20-14:30 Our Laboratory Experience About Interference of ACTH Measurement
Leyla Demir
Perspectives on women’s health care: Novel approaches for rare diseases, aging and cancer
Cinzia Marchese
Urinary exosomes as a novel source of biomarkers of kidney disease
Elisabetta Verderio Edwards
Inositol metabolites as biomarkers of peripheral complications in insulin resistant and diabetes patients
Mariano Bizzarri
Urinary biomarkers in kidney transplantation: Application of Mass Spectrometry to measure peptides and proteins
Halide Akbas
Usefulness of intraoperative parathyroid hormone monitoring during minimally invasive video-assisted parathyroidectomy
Elisabetta Stenner
The clinical laboratory and kidney disease
Edmund J. Lamb
14:30 – 14:45 Coffee Break & Posters
14:45 – 16:15 S16. Pediatric laboratory medicine


Canan Coker & Matthias Orth

S14. Medical guidelines and clinical decision making


Ebru Sezer

Oral Presentations


Tülay Köken & Özlem Gülbahar

14:45-14:55 Implementing a Total Laboratory Automation System: Experience of a University Laboratory
Raziye Yildiz
14:55-15:05 Emphasizing Clinical History In Thalassemia Screening

Esin Avci

15:05-15:15 Assessment Of PAPP-A And Serum Amiloid A Levels And Thyroid Functions In Patients With Metabolic Syndrome
Halil İbrahim Büyükbayram
15:15-15:25 The Relationship Between Mean Platelet Volume And Hba1c Levels
Arzu Kosem
15:25-15:35 Cardiac Biomarkers in Hemodialysis Patients
Rahile Arslan
15:35-15:45 Changes In Oxidative Stress Parameters And Inflammatory Markers In Hand Osteoarthritis Patients
Betul Ozbek Iptec
15:45-15:55 Vitamin D and Vitamin D Receptor: Another Aspect of Gestational Diabetes Mellitus
Seckin Ozgur Tekeli
15:55-16:05 Vitamin D Supplementation Does Not Improve Plasma Thiol/Disulfide Homeostasis
Cuma Mertoglu
16:05-16:15 The Importance Of Plasma Presepsin In Determining Stapler Line Leakage After Morbid Obesity
Pinar Kasapoglu


Newborn screening for metabolic and lysosomal diseases
Juergen Okun
Medical guidelines may not always be compatible with laboratory practice
Michel Langlois
The role of laboratory in diagnosis and management of familial hypercholesterolemia



Luis Masana

Laboratory and clinical cooperation in enhancing clinical decision making



Wytze Oosterhuis

Demand management (test utilization)


Ana Maria Simundic

15:45 – 16:15 S3. The utility of biomarkers in neurological disorders


Michael Meisner
The diagnosis and managemet of demantia
Sylvain Lehmann

16:15 – 16:30 Coffee Break & Posters
16:30 – 17:30 S8. Endocrinologist and laboratorian, a friendship under construction


Beyhan Omer & Roberto Verna

S7. The rise and fall of total error concept in laboratory medicine


Abdurrahman Coskun & Wytze Oosterhius

Oral Presentations


Asuman Gedikbaşı & Süleyman Demir

16:30-16:40 Association Of ABO and Rhesus Blood Groups With Cancer
Evin Kocaturk
16:40-16:50 Taurine Values In Postoperative Period After Cardiovascular Surgery
Saliha Aksun
16:50-17:00 Alkaline Phosphatase Interference in an Unconjugated Estriol Assay Causing a False Positive Down’s Syndrome Screening Result.
Ozlem Cakır Madenci
17:00-17:10 High Carrier Ratio In Healthy Subjects Of R202Q Mutation In MEFV Gene In Province Of
Burak Tanriverdi
17:10-17:20 Can Pregnancy Associated Plasma Protein-A be a Diagnostic Marker In Patients with Psoriasis?
Fikret Akyurek
17:20-17:30 Differences In Serum Levels Of Lysophosphatidic Acid And Orexin/Hypocretin In Normal Weight And Obese Patients, Along The Continuum From Health People To Alzheimer’s Disease.
Antonella Angiolillo


What do the endocrinologists expect from laboratory?
Ilhan Satman
Uncertainty or total allowable error: The big debate
Anders Kallner
The role of laboratory in metabolic bone disease
Howard Morris
From measurement to diagnosis: Uncertainty in laboratory medicine
Elvar Theodorsson
17:30 – 18:30 DEBATE



HbA1c will remain the preferred marker for assessing glycaemic control

For: Garry John



Against: Eric Kilpatrick

*may subject to change